Sobingsubing, E C.

HRN: 28-98-70  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/11/2026
05/17/2026
IV
500mg
Q8
Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines